Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier

Chiara Oltolini; Simona Piemontese; Marco Ripa; Raffaella Greco; Silvia Nozza; Consuelo Corti; Jacopo Peccatori; Paolo Scarpellini; Fabio Ciceri; Antonella Castagna

doi:10.1111/tid.13551

Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier

Transpl Infect Dis. 2021 Jun;23(3):e13551. doi: 10.1111/tid.13551. Epub 2021 Jan 5.

Authors

Chiara Oltolini¹, Simona Piemontese², Marco Ripa^{1

3}, Raffaella Greco², Silvia Nozza¹, Consuelo Corti², Jacopo Peccatori², Paolo Scarpellini¹, Fabio Ciceri^{2

3}, Antonella Castagna^{1

3}

Affiliations

¹ Clinic of Infectious Diseases, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy.
² Hematology and Bone Marrow Transplant, San Raffaele Scientific Institute, Milan, Italy.
³ University Vita-Salute San Raffaele, Milan, Italy.

PMID: 33351984
DOI: 10.1111/tid.13551

No abstract available

Keywords: HIV positive people; allogeneic hematopoietic stem cell transplant; antiretroviral therapy; haploidentical transplant; post-transplant cyclophosphamide.

Publication types

Letter

MeSH terms

Bone Marrow Transplantation*
Cyclophosphamide / therapeutic use
Graft vs Host Disease*
HIV Infections* / drug therapy
Hematologic Neoplasms* / therapy
Humans
Transplantation Conditioning

Substances

Cyclophosphamide